Autoimmune Clinical Trials in Shanghai, Shanghai Municipality
7 recruitingShanghai, Shanghai Municipality, China
Showing 1–7 of 7 trials
Recruiting
Phase 1
A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.
Autoimmune Disease
Changchun GeneScience Pharmaceutical Co., Ltd.48 enrolled1 locationNCT07366866
Recruiting
Early Phase 1
A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate-to-Severe Refractory Autoimmune Diseases
Moderate to Severe Refractory Autoimmune Disease
Grit Biotechnology22 enrolled1 locationNCT07333118
Recruiting
Phase 1
A Study of LUCAR-G79 in Subjects With Relapsed/Refractory Autoimmune Diseases
Relapsed/Refractory Autoimmune Diseases
Nanjing Legend Biotech Co.42 enrolled6 locationsNCT07049081
Recruiting
Early Phase 1
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases
Autoimmune
Neukio Biotherapeutics (Shanghai) Co., Ltd.8 enrolled1 locationNCT07144462
Recruiting
Assessing the Prevalence and Epidemiological Characteristics of Small Intestinal Bacterial Overgrowth (SIBO) in Patients With Autoimmune Gastritis(AIG) Through Hydrogen and Methane Breath Testing(HMBT).
Autoimmune Gastritis
RenJi Hospital220 enrolled1 locationNCT06946706
Recruiting
Phase 4
Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage
Postpartum HemorrhageSystemic Autoimmune Diseases
RenJi Hospital276 enrolled1 locationNCT06754371
Recruiting
Autoimmune Hepatitis Cohort in China
Autoimmune Hepatitis
Shanghai Jiao Tong University School of Medicine1,000 enrolled1 locationNCT05785793